Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.

Saved in:
Bibliographic Details
Title: Interleukin-2 is a potent latency reversal agent in people with treated HIV-1.
Authors: Freeman ML; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.; Center for Global Health and Diseases, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA., Clagett BM; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Leskov K; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA., Moisi D; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Yendewa GA; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Sieg SF; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Laird GM; Accelevir Diagnostics, Baltimore, MD, USA., Karn J; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, OH, USA., Jacobson JM; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Rodriguez B; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Lederman MM; Rustbelt Center for AIDS Research, Case Western Reserve University, Cleveland, OH, USA.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University/University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Source: Science advances [Sci Adv] 2025 Dec 19; Vol. 11 (51), pp. eaea4268. Date of Electronic Publication: 2025 Dec 19.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2375-2548
DOI:10.1126/sciadv.aea4268